| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |